An emerging role for escitalopram in the treatment of obsessive-compulsive disorder

References

• AbramowitzJS1997Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder:a quantitative reviewJ Consult Clin Psychol6544529103733
   PubMed Web of Science ®Google Scholar
• AckermanDLGreenlandS2002Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorderJ Clin Psychopharmacol223091712006902
   PubMed Web of Science ®Google Scholar
• BaldwinDSNairRV2005Escitalopram in the treatment of generalized anxiety disorderExpert Rev Neurother5443916026227
   PubMedGoogle Scholar
• BhatiaMSSapraS2004Escitalopram in trichotillomaniaEur Psychiatry192394015196611
   PubMed Web of Science ®Google Scholar
• BurkeWJ2002EscitalopramExpert Opin Investig Drugs11147786
   PubMed Web of Science ®Google Scholar
• BurkeWJGergelIBoseA2002Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatientsJ Clin Psychiatry63331612000207
   PubMed Web of Science ®Google Scholar
• BurkeWJKratochvilCJ2002Stereoisomers in psychiatry: the case of escitalopramPrim Care Companion J Clin Psychiatry420415014731
   PubMedGoogle Scholar
• BystritskyAAckermanDLRosenRM2004Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trialJ Clin Psychiatry65565815119922
   PubMed Web of Science ®Google Scholar
• CareyPDWarwickJNiehausDJ2004Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopramBMC Psychiatry43015482603
   PubMed Web of Science ®Google Scholar
• ChangJWKimCHLeeJD2003Single photon emission computed tomography imaging in obsessive-compulsive disorder and for stereotactic bilateral anterior cingulotomyNeurosurg Clin N Am142375012856491
   PubMed Web of Science ®Google Scholar
• CosgroveGRRauchSL2003Stereotactic cingulotomyNeurosurg Clin N Am142253512856490
   PubMed Web of Science ®Google Scholar
• DannonPNSassonYHirschmannS2000Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trialEur Neuropsychopharmacol10165910793318
   PubMed Web of Science ®Google Scholar
• DavidsonJRBoseAKorotzerA2004Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose studyDepress Anxiety192344015274172
   PubMed Web of Science ®Google Scholar
• DavidsonJRBoseANilR2004Long-term treatment of generalized anxiety disorder with escitalopramEur Psychiatry19Suppl 1S224
   Google Scholar
• Dell’OssoBNestadtGAllenA2006Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical reviewJ Clin Psychiatry676001016669725
   PubMed Web of Science ®Google Scholar
• DhillonSScottLJPloskerGL2006Escitalopram:a review of its use in the management of anxiety disordersCNS Drugs207639016953656
   PubMed Web of Science ®Google Scholar
• EddyKTDutraLBradleyR2004A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorderClin Psychol Rev2410113015533282
   PubMed Web of Science ®Google Scholar
• FallonBAMathewSJ2000Biological therapies for obsessive-compulsive disorderJ Psychiatr Pract61132815990479
   PubMedGoogle Scholar
• FinebergNATonnoirBLemmingO2007Escitalopram prevents relapse of obsessive-compulsive disorderEur Neuropsychopharmacol17430917240120
   PubMed Web of Science ®Google Scholar
• GrantJEPotenzaMN2006Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuationInt Clin Psychopharmacol21203916687991
   PubMed Web of Science ®Google Scholar
• HewlettWAVinogradovSAgrasWS1992Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorderJ Clin Psychopharmacol12420301474179
   PubMed Web of Science ®Google Scholar
• HollanderEFriedbergJPWassermanSAbramowitzJSHoutsAC2005The case for the OCD spectrumConcepts and controversies in obsessive-compulsive disorderNew YorkSpringer95118
   Google Scholar
• HyttelJBogesoKPPerregaardJ1992The pharmacological effect of citalopram residues in the (S)-(+)-enantiomerJ Neural Transm Gen Sect88157601632943
   PubMed Web of Science ®Google Scholar
• JangJHKwonJSJangDP2006A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorderAm J Psychiatry1631202716816225
   PubMed Web of Science ®Google Scholar
• JungHHKimCHChangJH2006Bilateral anterior cingulotomy for refractory obsessive-compulsive disorder: long-term follow-up resultsStereotact Funct Neurosurg84184916912517
   PubMed Web of Science ®Google Scholar
• KaplanAHollanderE2003A review of pharmacologic treatments for obsessive-compulsive disorderPsychiatr Serv541111812883138
   PubMed Web of Science ®Google Scholar
• KarnoMGoldingJMSorensonSB1988The epidemiology of obsessive-compulsive disorder in five US communitiesArch Gen Psychiatry45109493264144
   PubMed Web of Science ®Google Scholar
• KasperSSteinDJLoftH2005Escitalopram in the treatment of social anxiety disorder:randomised, placebo-controlled, flexible-dosage studyBr J Psychiatry186222615738503
   PubMed Web of Science ®Google Scholar
• KirkcaldyRDKimTJCarneyCP2004A somatoform variant of obsessive-compulsive disorder: a case report of OCD presenting with persistent vomitingPrim Care Companion J Clin Psychiatry6195815514688
   PubMedGoogle Scholar
• LaderMStenderKBurgerV2004Efficacy and tolerability of escitalopram in 12- and 24 week treatment of social anxiety disorder: randomised, double-blind, placebo-controlled, fixed-dose studyDepress Anxiety19241815274173
   PubMed Web of Science ®Google Scholar
• LepolaUMLoftHReinesEH2003Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary careInt Clin Psychopharmacol18211712817155
   PubMed Web of Science ®Google Scholar
• McDougleCJEppersonCNPeltonGH2000A double-blind, placebo-controlled study of risperidone addition in serotonin reup-take inhibitor-refractory obsessive-compulsive disorderArch Gen Psychiatry5779480110920469
   PubMed Web of Science ®Google Scholar
• McDougleCJGoodmanWKLeckmanJF1993Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorderAm J Psychiatry15064798465885
   PubMed Web of Science ®Google Scholar
• McDougleCJGoodmanWKPriceLH1993The pharmacotherapy of obsessive-compulsive disorderPharmacopsychiatry26Suppl 12498378419
   PubMedGoogle Scholar
• McDougleCJPriceLHGoodmanWK1991A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder:lack of efficacyJ Clin Psychopharmacol11175841820757
   PubMed Web of Science ®Google Scholar
• MontgomerySANilRDurr-PalN2005A 24 week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorderJ Clin Psychiatry661270816259540
   PubMed Web of Science ®Google Scholar
• MoritzSRuferMFrickeS2005Quality of life in obsessive-compulsive disorder before and after treatmentCompr Psychiatry46453916275213
   PubMed Web of Science ®Google Scholar
• MundoEGuglielmoEBellodiL1998Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled studyInt Clin Psychopharmacol13219249817627
   PubMed Web of Science ®Google Scholar
• PallantiSHollanderEBienstockC2002Treatment non-response in OCD: methodological issues and operational definitionsInt J Neuropsychopharmacol51819112135542
   PubMed Web of Science ®Google Scholar
• PhelpsNJCatesME2005The role of venlafaxine in the treatment of obsessive-compulsive disorderAnn Pharmacother391364015585743
   PubMed Web of Science ®Google Scholar
• PraharajSK2004Escitalopram treatment of transvestic fetishism: a case reportGerman J Psychiatry7201
   Google Scholar
• SanchezCBergqvistPBBrennumLT2003Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activitiesPsychopharmacology (Berl)1673536212719960
   PubMed Web of Science ®Google Scholar
• SanchezCGrucaPBienE2003R-citalopram counteracts the effect of escitalopram in a rat conditioned fear stress model of anxietyPharmacol Biochem Behav75903712957234
   PubMed Web of Science ®Google Scholar
• SimpsonHBLiebowitzMRFoaEB2004Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorderDepress Anxiety192253315274171
   PubMed Web of Science ®Google Scholar
• SkoogGSkoogI1999A 40-year follow-up of patients with obsessive-compulsive disorderArch Gen Psychiatry56121710025435
   PubMed Web of Science ®Google Scholar
• StarcevicV2005Issues in the pharmacological treatment of anxiety disordersAustralas Psychiatry13371416403133
   PubMedGoogle Scholar
• SteinDJAndersenEWTonnoirB2007Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24 week studyCurr Med Res Opin237011117407626
   PubMed Web of Science ®Google Scholar
• StorustovuSSanchezCPorzgenP2004R-citalopram functionally antagonises escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporterBr J Pharmacol1421728015037515
   PubMed Web of Science ®Google Scholar
• von MoltkeLLGreenblattDJGiancarloGM2001Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopramDrug Metab Dispos291102911454728
   PubMed Web of Science ®Google Scholar